« Go Back
« Go Back
Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis
« Go Back
PIPE-791 inhibits LPA1 to promote myelination and limit neuroinflammation
« Go Back
PIPE-791, a potent brain-penetrant selective LPA1 antagonist, reduces neuroinflammation in vivo
« Go Back
